Clinical Trial Update: Viscum Album for TNBC on Adjuvant Pembrolizumab [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing Viscum Album in combination with adjuvant pembrolizumab for triple-negative breast cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Iscador (Viscum album)
• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Ilsan Cha hospital | Conditions: Breast Cancer, Triple Negative Breast Cancer | Phase 4 | Status: RECRUITING